83-2271-20　［受注停止］KRIBIOLISA Desmopressin （Minirin） ELISA 1 x 96 wells　KBI5010

特徴

• Description：Immunoassay for quantitative estimation of Desmopressin in human serum, plasma and tissue extract.
• Desmopressin （DDAVP/Stimate/Minirin） is a medication used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and high blood urea levels.Desmopressin （dDAVP）, a synthetic analogue of 8-arginine vasopressin （ADH）, is an antidiuretic peptide drug modified by deamination of 1-cysteine and substitution of 8-L-arginine by 8-D-arginine.
• ADH is an endogenous pituitary hormone that has a crucial role in the control of the water content in the body.
• Upon release from the stimulation of increased plasma osmolarity or decreased circulating blood volume, ADH mainly acts on the cells of the distal part of the nephron and the collecting tubules in the kidney.
• The hormone interacts with V1, V2 or V3 receptors with differing signal cascade systems.
• About the kit：
• - Uses anti-idiotypic antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity.
• - Recovery rates are between 85 - 115％
• - Ready to use with a standard protocol with break-apart pre-coated wells
• - Validated as per US FDA guidelines for Bioassays
• - Optimized for matrix effects to ensure higher sensitivity.
• - Shelf life： 1 year
• The Desmopressin ELISA is a competitive immunoassay for the determination of Desmopressin.
• The antiserum is captured by antibodies coated on a 96-well plate.
• A constant concentration of Biotin Concentrate and varying concentrations of unlabeled standard or sample compete for binding specifically to the antiserum.
• Captured Bt-tracer is subsequently bound by SA-HRP （streptavidin-conjugated horseradish peroxidase）, which produces a soluble colored product after a substrate is added.
• The enzyme reaction is stopped by dispensing an acidic solution （H2SO4） into the wells after 10 min at room temperature turning the solution from blue to yellow.
• The optical density （OD） of the solution at 450 nm is inversely proportional to the amount of specific Desmopressin bound.